CD4 and breast cancer: showed that pyroptosis-inducible therapy increased the infiltration of CD8+ cells, CD4+ T cells, and NK cells in mammary tumor grafts, and the pyroptosis of less than 15% of tumor cells was sufficient to clear all 4T1 experimental breast tumors (84).